The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment
Breast cancer is one of the most diagnosed cancers worldwide, with an incidence of 47.8%. Its treatment includes surgery, radiotherapy, chemotherapy, and antibodies giving a mortality of 13.6%. Breast tumor development is driven by a variety of signaling pathways with high heterogeneity of surface r...
Main Authors: | Víctor Marín, Viviana Burgos, Rebeca Pérez, Durvanei Augusto Maria, Paulo Pardi, Cristian Paz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/13/10737 |
Similar Items
-
Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian Cancers
by: Yun-Ju Huang, et al.
Published: (2020-10-01) -
Assessing the Hepatic Safety of Epigallocatechin Gallate (EGCG) in Reproductive-Aged Women
by: Hiba Siblini, et al.
Published: (2023-01-01) -
Topical Epigallocatechin Gallate (EGCG) 1% for Chronic Plantar Ulcers in Leprosy
by: Riyana Noor Oktaviyanti, et al.
Published: (2020-07-01) -
Therapeutic effects of epigallocatechin and epigallocatechin gallate on the allergic reaction of αs1-casein sensitized mice
by: Qianqian Zhang, et al.
Published: (2023-05-01) -
The Potential of Epigallocatechin Gallate (EGCG) in Targeting Autophagy for Cancer Treatment: A Narrative Review
by: Elena Ferrari, et al.
Published: (2022-05-01)